results found
In this collection of charts, we use a variety of data sources to explore trends in health outcomes, quality of care, and spending on treatment for people in the U.S. with diabetes and other endocrine disorders. In the U.S., diabetes …
The cost of prescription drugs has become a hot-button issue with consumers and policymakers. One in four people taking prescription drugs report difficulty affording their medication and recent Kaiser Family Foundation opinion polling has found bipartisan support for government action …
Prescription drug spending grew rapidly between 2014 and 2015, but increases have been more modest recently. Several studies by the federal government, pharmacy benefit managers, and insurers point to high prices for new “specialty” drugs as driving the spike, in …
Cost-sharing between insurance providers and patients has increasingly become a topic of public discussion. In particular, the increasing proportion that enrollees are paying for healthcare has been an area of concern. For example, in the ten years from 2006 to …
Total health spending is a function of both price paid to providers or for drugs and the volume of services used. These charts explore prices and use of health services in the U.S. relative to comparable countries (those with both …
With deaths from opioid overdose rising steeply in recent years, and a large segment of the population reporting knowing someone who has been addicted to prescription painkillers, the breadth of the opioid crisis should come as no surprise, affecting people …
This collection of charts complements our brief, “A look at how the opioid crisis has affected people with employer coverage,” which uses claims data from large employers to examine how the opioid crisis has affected people with large employer coverage, …
This chart collection accompanies a related brief that explores recent trends in spending on prescription drugs among people with employer coverage, with a particular focus on people with high drug spending and high out-of-pocket drug spending. …
This brief is the result of a collaboration between the Kaiser Family Foundation and the United States Bureau of Economic Analysis. Cynthia Cox is with the Kaiser Family Foundation; Abe Dunn, Lindsey Rittmueller, and Bryn Whitmire are with the Bureau …
Compared to similar countries, the United States has higher rates of mortality for most of the leading causes of death, and generally performs worse on a variety of quality indicators. Diabetes and endocrine diseases are no exception. There has been …